Oral statins and increased bone-mineral density in postmenopausal women
The LancetPublished 1 June 2000
CJ Edwards, D.J. Hart, TD Spector
Citations328
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A significant increase of bone-mineral density associated with taking statins in postmenopausal women is reported, suggesting that the cholesterol-lowering drugs statins increase bone formation.
Abstract
Experimental evidence suggests that the cholesterol-lowering drugs statins increase bone formation. We report a significant increase of bone-mineral density associated with taking statins in postmenopausal women.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
ScienceStimulation of Bone Formation in Vitro and in Rodents by Statins
1,779 Citations1999Gregory R. Mundy, R.J. Burriss Garrett +7 more
It is shown that the statins, drugs widely used for lowering serum cholesterol, also enhance new bone formation in vitro and in rodents, and may have therapeutic applications for the treatment of osteoporosis.
Proceedings of the National Academy of SciencesMevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
1,635 Citations1980Alfred W. Alberts, J Chen +18 more
It was shown that mevinolin was an orally active cholesterol-lowering agent in the dog and orally administered sodium mevinolinate was an active inhibitor of cholesterol synthesis in an acute assay.
Proceedings of the National Academy of SciencesAlendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation <i>in vitro</i>
679 Citations1999John Fisher, Michael J. Rogers +8 more
The hypothesis that alendronate, acting directly on osteoclasts, inhibits a rate-limiting step in the cholesterol biosynthesis pathway, essential for osteoclast function, is supported.
Annals of the Rheumatic DiseasesRelation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.
71 Citations1996M. E. Lloyd, D.J. Hart +5 more
There is a modest association between IGF-I concentrations and the development of DIP osteoarthritis and more severe or bilateral knee joint osteoartritis in women from the normal population, but no association with other forms of osteOarthritis, bone density, or fractures.